Cold Chain IQ | 06/08/2015
A late-stage biopharmaceutical company developing products in inflammation, oncology and biodefense, has recently published data demonstrating a heat stable vaccine formulation of a human papillomavirus (HPV) vaccine. [eventPDF]The work was conducted at the University of Colorado, Boulder by Drs. Randolph and Garcea and demonstrated the successful conversion of a commercial virus-like particle (VLP) based vaccine requiring cold-chain storage to a subunit, alum-adjuvanted, vaccine which is stabl...
To continue reading this story Click Here
Upcoming Events
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More